EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Integrative Strategies for Cardiovascular Risk Reduction: Synergy between Lifestyle Modifications and Pharmacotherapy

Weronika Mstowska, Ewa Byjoś, Mateusz Zbylut, Karolina Bury, Katarzyna Fabiś, Kamila Milewska, Sylwia Buczek, Patrycja Mateja, Hanna Naliuka, Katarzyna Młynarczyk

Quality in Sport · 29.03.2026 · 53 · 69368

DOI: 10.12775/qs.2026.53.69368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 29.03.2026. Verfasst von Weronika Mstowska und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular diseases (CVD) remain the leading cause of mortality worldwide, primarily driven by atherosclerosis. Dyslipidemia, characterized by elevated atherogenic lipoproteins, represents a key modifiable risk factor in both primary and secondary prevention.

Objective

This narrative review synthesizes current evidence on the integrative management of dyslipidemia, emphasizing the combined role of lifestyle modifications: physical activity, dietary patterns, weight management and established and emerging pharmacological therapies.

Methods

A narrative review of European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) guidelines, as well as peer-reviewed literature, was conducted. The analysis focused on lipid metabolism, nutritional strategies, physical activity, and lipid-lowering therapies ranging from statins to novel siRNA-based agents.

Results

Lifestyle interventions are the foundation of cardiovascular prevention. Regular physical activity (150–300 min/week) and weight reduction in obesity lead to meaningful improvements in lipid profiles. Dietary modifications, particularly reducing saturated fats and improving fat quality, contribute to lowering LDL-C and triglyceride levels. In patients at high or very high cardiovascular risk, lifestyle measures alone are frequently insufficient, necessitating pharmacotherapy, primarily statins, with add-on agents such as ezetimibe, PCSK9 inhibitors, or inclisiran to achieve lipid targets.

Conclusion

A comprehensive strategy integrating sustained lifestyle modification with intensified pharmacotherapy provides the greatest reduction in CVD risk. Understanding the synergistic effects of these interventions may improve long-term adherence and overall treatment effectiveness.

Zitieren

APA

Mstowska, W., Byjoś, E., Zbylut, M., Bury, K., Fabiś, K., Milewska, K., Buczek, S., Mateja, P., Naliuka, H., & Młynarczyk, K. (2026). Integrative Strategies for Cardiovascular Risk Reduction: Synergy between Lifestyle Modifications and Pharmacotherapy. Quality in Sport, 53, 69368. https://doi.org/10.12775/qs.2026.53.69368

Vancouver

Mstowska W, Byjoś E, Zbylut M, Bury K, Fabiś K, Milewska K, et al. Integrative Strategies for Cardiovascular Risk Reduction: Synergy between Lifestyle Modifications and Pharmacotherapy. Quality in Sport. 2026;53:69368. doi:10.12775/qs.2026.53.69368

BibTeX
@article{Mstowska2026,
  author = {Mstowska, Weronika and Byjoś, Ewa and Zbylut, Mateusz and Bury, Karolina and Fabiś, Katarzyna and Milewska, Kamila and Buczek, Sylwia and Mateja, Patrycja and Naliuka, Hanna and Młynarczyk, Katarzyna},
  title = {Integrative Strategies for Cardiovascular Risk Reduction: Synergy between Lifestyle Modifications and Pharmacotherapy},
  journal = {Quality in Sport},
  year = {2026},
  volume = {53},
  pages = {69368},
  doi = {10.12775/qs.2026.53.69368}
}
Kostenlos starten →